drugset / Trial / NCT07612813

A Study to Evaluate the Safety and Pharmacokinetics of AZD7760 in Healthy Japanese Adults

NCT07612813 ↗

Phase 1 Recruiting 18 enrolled AstraZeneca Parexel · collab
RandomizedParallel-groupDouble-blindPrevention

Summary

The purpose of this study is to evaluate the safety and PK of AZD7760 when given as an intravenous (IV) infusion to healthy Japanese adult participants.

Timeline

Start
2026-06-29
Primary completion
2027-09-13
Completion
2027-09-13

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD7745 Monoclonal antibody — Intravenous
Subject Suvratoxumab Monoclonal antibody — Intravenous